Patent · US Active

Antibodies against clostridium difficile toxins and uses thereof

US9217029B2 · kind B2 · utility

1Cited by

21References

25Claims

0Family size

Assignees

University of Massachusetts · US
E.R. SQUIBB & SONS, L.L.C. · US

Inventors

Donna M. Ambrosino · Brookline, US
Gregory Babcock · Marlborough, US
Teresa J. Broering · Brookline, US
Robert Graziano · Princeton, US
Hector Javier HERNANDEZ · Canton, US
Israel Lowy · Dobbs Ferry, US
Robert Mandell · Moraga, US
Deborah MOLRINE · Newton, US
William D. Thomas · San Jose, US
Hui Zhang · Jinan, CN

Key dates

Filing date	Nov 14, 2013
Grant date	Dec 22, 2015
Priority date	—
Expiry date	Nov 14, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S424/809
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies that specifically bind to toxins of C. difficile, antigen binding portions thereof, and methods of making and using the antibodies and antigen binding portions thereof are provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.